FDA warns against common cold remedies containing risky ingredient
FDA urges immediate halt to PPA containing nonprescription cold relievers and diet pills after advisories warn of hemorrhagic stroke risk mainly for young women. Consumers should seek pseudoephedrine alternatives or nasal sprays and doctors for diet pills. Some retailers pulled Contac products. Walgreens removed all PPA items from 32,000 stores.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
FDA
Charles Ganley
Ganley
SmithKline Beecham Consumer Healthcare
FDA warns on PPA in over the counter products
The FDA urged avoiding phenylpropanolamine PPA found in many decongestants and appetite suppressants. Labels must list ingredients and many formulas of popular brands contain no PPA. The agency warned risk of hemorrhagic stroke increases among young women within days of first PPA dose, urging doctors and manufacturers to act and providing hotline numbers.
MENTIONED IN THIS ARTICLE
FDA
Consumer Healthcare Products Association
Yale University
Also Mentioned on This Page
Novartis Corp
Triaminic and
Tavist D. Whitehall-Robins
Virtualbasin.com
Traceybright
Tracey Bright
Imogene Worley
Crown
Odessa
Texas
Bill Vance
Texas Court of Criminal Appeals
Billvance.com
Eersdg
Jcpenney
Lestores
Catalog B
Jcpenney.com
Bose
Boyd's
Calvin Klein
Easy Spirit
Hanes
Nike Max
Music City